https://www.sciencedaily.com/news/health_medicine/women's_health/ Women's health and fitness. Information on women's health issues such as sexual health, birth control, pregnancy and healthy aging. Updated daily. en-us Fri, 17 Apr 2026 08:54:06 EDT Fri, 17 Apr 2026 08:54:06 EDT 60 https://www.sciencedaily.com/images/scidaily-logo-rss.png https://www.sciencedaily.com/news/health_medicine/women's_health/ For more science news, visit ScienceDaily. https://www.sciencedaily.com/releases/2026/04/260411022027.htm A new nanodisc-based platform lets scientists study viral proteins in a form that closely mimics real viruses, revealing how antibodies truly recognize them. This approach uncovered hidden interactions in viruses like HIV and Ebola that traditional methods missed. By recreating the virus’s membrane environment, researchers can better understand how immune defenses work. The technique could speed up the development of more effective vaccines. Sun, 12 Apr 2026 06:42:12 EDT https://www.sciencedaily.com/releases/2026/04/260411022027.htm https://www.sciencedaily.com/releases/2026/04/260406080131.htm Scientists have identified a little-known receptor, GPR133, as a powerful regulator of bone strength. By activating it with a newly discovered compound called AP503, they were able to boost bone density in mice and counteract osteoporosis-like damage. The finding opens the door to a new kind of treatment that could not only prevent bone loss but also rebuild weakened bones, offering fresh hope for millions affected by osteoporosis, especially aging populations. Mon, 06 Apr 2026 08:14:33 EDT https://www.sciencedaily.com/releases/2026/04/260406080131.htm https://www.sciencedaily.com/releases/2026/03/260331001054.htm A breakthrough urine test could dramatically speed up how doctors treat urinary tract infections, identifying the right antibiotic in under six hours instead of waiting days. By testing directly from urine—skipping the usual lab culturing step—the method quickly shows which drugs stop bacterial growth and which don’t. In trials involving hundreds of patient samples, the test proved highly accurate, matching standard methods in over 96% of cases. Tue, 31 Mar 2026 01:45:05 EDT https://www.sciencedaily.com/releases/2026/03/260331001054.htm https://www.sciencedaily.com/releases/2026/03/260330210905.htm Deep sleep does far more than rest the body — it activates a powerful brain-driven system that controls growth hormone, fueling muscle and bone strength, metabolism, and even mental performance. Scientists have now mapped the neural circuits behind this process, uncovering a delicate feedback loop in which sleep boosts growth hormone, and that same hormone helps regulate wakefulness. Mon, 30 Mar 2026 21:39:42 EDT https://www.sciencedaily.com/releases/2026/03/260330210905.htm https://www.sciencedaily.com/releases/2026/03/260326075552.htm A new study reveals that high doses of antioxidants—often seen as harmless or beneficial—may actually impact future generations. Male mice given common supplements like NAC produced offspring with subtle but significant facial and skull changes. Researchers believe this is tied to altered sperm DNA, even though the fathers showed no outward health issues. Fri, 27 Mar 2026 08:41:19 EDT https://www.sciencedaily.com/releases/2026/03/260326075552.htm https://www.sciencedaily.com/releases/2026/03/260326075550.htm Scientists have uncovered a hidden reason why cancer treatments don’t work equally well for everyone. Certain drugs can become trapped inside lysosomes within tumor cells, forming slow-release reservoirs that create uneven drug distribution. This means some cancer cells are heavily exposed while others are barely affected. Understanding this process could help doctors better tailor treatments and improve outcomes. Fri, 27 Mar 2026 08:31:17 EDT https://www.sciencedaily.com/releases/2026/03/260326075550.htm https://www.sciencedaily.com/releases/2026/03/260325005920.htm Researchers have identified a crucial ion channel, TMEM175, that acts like an overflow valve in the cell’s recycling system. It regulates acidity inside lysosomes, ensuring they function properly. When TMEM175 is faulty, toxic buildup can occur, contributing to diseases like Parkinson’s. This breakthrough reveals a promising new target for future therapies. Thu, 26 Mar 2026 07:35:07 EDT https://www.sciencedaily.com/releases/2026/03/260325005920.htm https://www.sciencedaily.com/releases/2026/03/260323005543.htm Postmenopausal women may have a powerful new edge in the battle against weight gain. A Mayo Clinic study found that those using menopausal hormone therapy while taking the obesity drug tirzepatide lost about 35% more weight than those on the drug alone. The findings hint at a surprising synergy between hormones and cutting-edge weight-loss medications, potentially opening the door to more effective, personalized treatments for millions of women facing increased cardiometabolic risks after menopause. Mon, 23 Mar 2026 21:06:37 EDT https://www.sciencedaily.com/releases/2026/03/260323005543.htm https://www.sciencedaily.com/releases/2026/03/260323005542.htm A new study suggests a widely used bone hormone could help relieve chronic back pain in an unexpected way. Instead of just strengthening bone, it appears to stop pain-sensing nerves from growing into damaged spinal areas. In animal models, this led to stronger spinal tissue and reduced pain sensitivity. The findings hint at a future treatment that tackles back pain at its biological roots. Mon, 23 Mar 2026 22:28:06 EDT https://www.sciencedaily.com/releases/2026/03/260323005542.htm https://www.sciencedaily.com/releases/2026/03/260319044719.htm A common oral bacterium tied to gum disease may help spark and fuel breast cancer, according to new research. Scientists discovered it can travel through the bloodstream to breast tissue, where it causes DNA damage and speeds tumor growth and spread. It also appears to make cancer cells more aggressive and resistant to therapy. The effect is even stronger in people with BRCA1 mutations, raising new questions about the role of oral health in cancer risk. Thu, 19 Mar 2026 23:37:17 EDT https://www.sciencedaily.com/releases/2026/03/260319044719.htm https://www.sciencedaily.com/releases/2026/03/260319044659.htm A shingles vaccine might double as a powerful heart protector. In people already at high risk, it cut major cardiac events by 46% and deaths by an impressive 66% within a year. Scientists think preventing shingles may also stop clot-related complications that can lead to heart attacks and strokes. The effect is so strong, it rivals the benefits of quitting smoking. Fri, 20 Mar 2026 08:10:25 EDT https://www.sciencedaily.com/releases/2026/03/260319044659.htm https://www.sciencedaily.com/releases/2026/03/260318033143.htm Scientists have mapped the genetics of cancer in cats for the first time at scale, uncovering major overlaps with human cancers. Key mutations—like those linked to breast cancer—appear in both species, and some human cancer drugs may also work in cats. Because pets share our environments, these similarities could reveal shared causes of cancer. The research could lead to new treatments that benefit both animals and humans. Wed, 18 Mar 2026 19:12:17 EDT https://www.sciencedaily.com/releases/2026/03/260318033143.htm https://www.sciencedaily.com/releases/2026/03/260317015933.htm mRNA vaccines saved millions of lives during COVID-19 but have limitations like waning immunity and complex production. Scientists are now testing a new platform called DoriVac, which uses folded DNA nanostructures to better control how the immune system responds. In early studies, it produced strong antibody and T cell responses in both mice and human models. Researchers say it could lead to more stable, easier-to-manufacture vaccines for diseases like COVID-19, HIV, and Ebola. Tue, 17 Mar 2026 01:59:33 EDT https://www.sciencedaily.com/releases/2026/03/260317015933.htm https://www.sciencedaily.com/releases/2026/03/260315225121.htm A redesigned cancer immunotherapy is showing striking early results after decades of disappointment with similar drugs. Researchers engineered a more powerful CD40 agonist antibody and changed how it’s delivered—injecting it directly into tumors instead of into the bloodstream. In a small clinical trial of 12 patients with metastatic cancers, six saw their tumors shrink and two experienced complete remission. Mon, 16 Mar 2026 20:18:42 EDT https://www.sciencedaily.com/releases/2026/03/260315225121.htm https://www.sciencedaily.com/releases/2026/03/260309225222.htm Colorblindness may be doing more than making traffic lights confusing — it could also be hiding a life-threatening warning sign. Researchers analyzing millions of medical records found that people with bladder cancer who are also colorblind have a 52% higher mortality rate over 20 years compared to those with normal vision. The likely reason: many people with color vision deficiency struggle to see red, making it harder to notice blood in urine, the most common early sign of bladder cancer. Tue, 10 Mar 2026 01:49:43 EDT https://www.sciencedaily.com/releases/2026/03/260309225222.htm https://www.sciencedaily.com/releases/2026/03/260309225152.htm Cancer often begins when the genetic instructions that guide our cells become scrambled, allowing cells to grow uncontrollably. Now, scientists at EMBL have developed an AI-powered system called MAGIC that can automatically spot and tag cells showing early signs of chromosomal trouble—tiny DNA-filled structures known as micronuclei that are linked to future cancer development. Tue, 10 Mar 2026 19:12:39 EDT https://www.sciencedaily.com/releases/2026/03/260309225152.htm https://www.sciencedaily.com/releases/2026/03/260308201618.htm Pre-workout supplements promising extra energy for workouts may come with a hidden cost: severely reduced sleep. A study of people aged 16–30 found users were more than twice as likely to sleep five hours or less per night. Many of these products pack huge doses of caffeine and stimulants that can linger for hours. Researchers say the findings raise concerns about the impact on young people’s health and development. Mon, 09 Mar 2026 17:02:26 EDT https://www.sciencedaily.com/releases/2026/03/260308201618.htm https://www.sciencedaily.com/releases/2026/03/260306224220.htm Scientists have revealed how the body’s microscopic cold sensor, TRPM8, detects both chilly temperatures and the cooling effect of menthol. The discovery finally shows how the sensation of “cool” works at the molecular level—and could inspire new treatments for pain and eye disorders. Sun, 08 Mar 2026 01:31:56 EST https://www.sciencedaily.com/releases/2026/03/260306224220.htm https://www.sciencedaily.com/releases/2026/03/260305223240.htm A Rutgers-led study found that eating less protein may help slow liver cancer in people with impaired liver function. When damaged livers can’t properly clear toxic ammonia from protein metabolism, the excess ammonia can feed tumor growth. In mice, reducing dietary protein lowered ammonia levels, slowed tumor growth, and significantly improved survival. Fri, 06 Mar 2026 05:17:57 EST https://www.sciencedaily.com/releases/2026/03/260305223240.htm https://www.sciencedaily.com/releases/2026/03/260305223204.htm Researchers created an AI-driven liquid biopsy that scans patterns in fragments of DNA circulating in the blood. The system detected early liver fibrosis and cirrhosis—conditions that often go unnoticed until serious damage occurs. By analyzing genome-wide DNA fragmentation patterns rather than specific mutations, the approach captures hidden signals about a person’s overall health. Early detection could help doctors treat liver disease sooner and potentially prevent cancer. Fri, 06 Mar 2026 00:20:31 EST https://www.sciencedaily.com/releases/2026/03/260305223204.htm https://www.sciencedaily.com/releases/2026/03/260303145705.htm A sweeping new study reveals that what’s on your plate may directly shape the pesticides circulating in your body. Researchers found that people who eat more fruits and vegetables known to carry higher pesticide residues—such as strawberries, spinach, and bell peppers—also have significantly higher levels of those chemicals in their urine. While produce remains a cornerstone of a healthy diet, the findings highlight how everyday food choices can drive real-world exposure to substances linked to cancer, hormone disruption, and developmental harm. Wed, 04 Mar 2026 13:09:52 EST https://www.sciencedaily.com/releases/2026/03/260303145705.htm https://www.sciencedaily.com/releases/2026/03/260303050624.htm Scientists have identified a crucial molecular switch that decides whether pancreatic cancer cells resist chemotherapy or respond to it. The key player, a gene called GATA6, keeps tumours in a more structured and treatable form—but it gets shut down by an overactive KRAS-driven pathway. When researchers blocked that pathway, GATA6 levels rebounded and cancer cells became more sensitive to chemo. The discovery could help turn some of the toughest pancreatic tumours into ones doctors can better control. Tue, 03 Mar 2026 11:33:04 EST https://www.sciencedaily.com/releases/2026/03/260303050624.htm https://www.sciencedaily.com/releases/2026/02/260227061818.htm Heart disease is on track to tighten its grip on American women. New projections from the American Heart Association warn that over the next 25 years, cardiovascular disease will rise sharply, driven largely by a surge in high blood pressure, diabetes, and obesity. By 2050, nearly 60% of women in the U.S. could have high blood pressure, and close to one in three women ages 22 to 44 may already be living with some form of heart disease. Fri, 27 Feb 2026 06:18:18 EST https://www.sciencedaily.com/releases/2026/02/260227061818.htm https://www.sciencedaily.com/releases/2026/02/260222092258.htm Scientists at Stanford Medicine have unveiled a bold new kind of “universal” vaccine that could one day protect against everything from COVID-19 and the flu to bacterial pneumonia and even common allergens. Instead of targeting a specific virus or bacterium, the nasal spray vaccine supercharges the lungs’ own immune defenses, keeping them on high alert for months. In mice, it slashed viral levels, prevented severe illness, and even blocked allergic reactions. Mon, 23 Feb 2026 08:45:18 EST https://www.sciencedaily.com/releases/2026/02/260222092258.htm https://www.sciencedaily.com/releases/2026/02/260216084527.htm A mysterious RNA found in breast cancer led scientists to uncover an entire hidden class of cancer-specific RNAs across dozens of tumor types. These molecules form unique molecular signatures that identify cancer type and subtype with remarkable accuracy. Some even drive tumor growth and metastasis. Because many are released into the bloodstream, a simple blood test can track how patients respond to treatment and predict survival. Tue, 17 Feb 2026 03:50:37 EST https://www.sciencedaily.com/releases/2026/02/260216084527.htm https://www.sciencedaily.com/releases/2026/02/260216044006.htm Northwestern researchers have shown that when it comes to cancer vaccines, arrangement can be just as important as ingredients. By repositioning a small fragment of an HPV protein on a DNA-based nanovaccine, the team dramatically strengthened the immune system’s attack on HPV-driven tumors. One specific design slowed tumor growth, extended survival in animal models, and unleashed far more cancer-killing T cells than other versions made with the exact same components. Wed, 18 Feb 2026 10:00:32 EST https://www.sciencedaily.com/releases/2026/02/260216044006.htm https://www.sciencedaily.com/releases/2026/02/260213223918.htm Scientists at Michigan State University have uncovered the molecular “switch” that powers sperm for their final, high-speed dash toward an egg. By tracking how sperm use glucose as fuel, the team discovered how dormant cells suddenly flip into overdrive, burning energy in a carefully controlled, multi-step process. A key enzyme, aldolase, helps convert sugar into the burst of power needed for fertilization, while other enzymes act like traffic controllers directing the flow of fuel. Sat, 14 Feb 2026 10:47:27 EST https://www.sciencedaily.com/releases/2026/02/260213223918.htm https://www.sciencedaily.com/releases/2026/02/260212234216.htm Fish oil’s cancer-fighting reputation may hinge on a little-known gene. Researchers discovered that omega-3s like EPA and DHA help curb colorectal cancer only when the enzyme ALOX15 is present. Without it, fish oil sometimes increased tumor growth in mice—especially DHA. The results suggest that not all supplements work the same way, and genetics could determine who truly benefits. Fri, 13 Feb 2026 09:20:25 EST https://www.sciencedaily.com/releases/2026/02/260212234216.htm https://www.sciencedaily.com/releases/2026/02/260210040604.htm Scientists have uncovered a surprising way tumors turn the immune system to their advantage. Researchers at the University of Geneva found that neutrophils—normally frontline defenders against infection—can be reprogrammed inside tumors to fuel cancer growth instead. Once exposed to the tumor environment, these immune cells begin producing a molecule called CCL3 that actively promotes tumor progression. Tue, 10 Feb 2026 10:28:42 EST https://www.sciencedaily.com/releases/2026/02/260210040604.htm https://www.sciencedaily.com/releases/2026/02/260210040559.htm Human evolution has long been tied to growing brain size, and new research suggests prenatal hormones may have played a surprising role. By studying the relative lengths of index and ring fingers — a clue to oestrogen and testosterone exposure in the womb — researchers found that higher prenatal estrogen was linked to larger head size in newborn boys. Tue, 10 Feb 2026 09:42:37 EST https://www.sciencedaily.com/releases/2026/02/260210040559.htm https://www.sciencedaily.com/releases/2026/02/260209064254.htm Scientists have discovered why ovarian cancer spreads so rapidly through the abdomen. Cancer cells enlist normally protective abdominal cells, forming mixed groups that work together to invade new tissue. These helper cells lead the way, allowing cancer to spread faster and resist chemotherapy. The findings uncover a critical weakness that future treatments may target. Mon, 09 Feb 2026 06:51:03 EST https://www.sciencedaily.com/releases/2026/02/260209064254.htm https://www.sciencedaily.com/releases/2026/02/260207092904.htm A major study suggests menopause is linked to changes in brain structure, mental health, and sleep. Brain scans revealed grey matter loss in areas tied to memory and emotional regulation, while many women reported increased anxiety, depression, and fatigue. Hormone therapy did not reverse these effects, though it may slow age-related declines in reaction speed. Researchers say menopause could represent an important turning point for brain health. Sat, 07 Feb 2026 09:52:48 EST https://www.sciencedaily.com/releases/2026/02/260207092904.htm https://www.sciencedaily.com/releases/2026/02/260206012229.htm Colorectal cancer has long baffled scientists because, unlike most tumors, patients often do better when their cancers are packed with immune-suppressing regulatory T cells. New research finally explains why. Scientists discovered that these T cells aren’t all the same: one subtype actually helps keep tumors in check, while another shields cancer from immune attack. The balance between these “good” and “bad” cells can determine whether a tumor grows or shrinks. Fri, 06 Feb 2026 11:03:34 EST https://www.sciencedaily.com/releases/2026/02/260206012229.htm https://www.sciencedaily.com/releases/2026/02/260204114343.htm As bird flu continues to circulate in animals and spill over into humans, researchers are racing to stop it before it adapts to spread widely between people. A new nasal spray vaccine showed strong protection against H5N1 in animal tests, outperforming traditional flu shots. Because it targets the nose and lungs, it may prevent infection at the earliest stage. Wed, 04 Feb 2026 11:43:43 EST https://www.sciencedaily.com/releases/2026/02/260204114343.htm https://www.sciencedaily.com/releases/2026/02/260203030537.htm Scientists are digging into why heart disease risk in type 2 diabetes differs between men and women—and sex hormones may be part of the story. In a large Johns Hopkins study, men with higher testosterone had lower heart disease risk, while rising estradiol levels were linked to higher risk. These hormone effects were not seen in women. The results point toward more personalized approaches to heart disease prevention in diabetes. Wed, 04 Feb 2026 02:21:09 EST https://www.sciencedaily.com/releases/2026/02/260203030537.htm https://www.sciencedaily.com/releases/2026/01/260129080443.htm Collagen pills sound like a shortcut to younger skin, but solid evidence doesn’t back them up. Higher-quality studies show little benefit, and your body doesn’t absorb collagen in the way ads suggest. Some supplements may even pose safety concerns and lack proper testing. Experts recommend focusing on proven habits like sunscreen, retinoids, and a nutrient-rich diet instead. Thu, 29 Jan 2026 23:30:21 EST https://www.sciencedaily.com/releases/2026/01/260129080443.htm https://www.sciencedaily.com/releases/2026/01/260129080432.htm Researchers have discovered how pancreatic cancer reprograms its surroundings to spread quickly and stealthily. By using a protein called periostin, the tumor remodels nearby tissue and invades nerves, which helps cancer cells travel and form metastases. This process also creates a tough, fibrous barrier that makes treatments less effective. Targeting periostin could help stop this invasion before it starts. Fri, 30 Jan 2026 07:44:14 EST https://www.sciencedaily.com/releases/2026/01/260129080432.htm https://www.sciencedaily.com/releases/2026/01/260128075350.htm Scientists in South Korea have discovered that one of the most common malignant brain tumors in young adults may begin years before a tumor can be seen. IDH-mutant glioma, long treated by removing visible tumor tissue, actually starts when normal-looking brain cells quietly acquire a cancer-linked mutation and spread through the brain’s cortex. Using advanced genetic mapping and animal models, researchers traced the cancer’s true origin to glial progenitor cells that appear healthy at first. Wed, 28 Jan 2026 07:53:50 EST https://www.sciencedaily.com/releases/2026/01/260128075350.htm https://www.sciencedaily.com/releases/2026/01/260128075332.htm Scientists at Mount Sinai have unveiled a bold new way to fight metastatic cancer by turning the tumor’s own defenses against it. Instead of attacking cancer cells head-on, the experimental immunotherapy targets macrophages—immune cells that tumors hijack to shield themselves from attack. By eliminating or reprogramming these “bodyguards,” the treatment cracks open the tumor’s protective barrier and allows the immune system to flood in and destroy the cancer. Fri, 30 Jan 2026 01:05:29 EST https://www.sciencedaily.com/releases/2026/01/260128075332.htm https://www.sciencedaily.com/releases/2026/01/260127112137.htm Scientists at KAIST have found a way to turn a tumor’s own immune cells into powerful cancer fighters—right inside the body. Tumors are packed with macrophages, immune cells that should attack cancer but are usually silenced by the tumor environment. By injecting a specially designed drug directly into tumors, researchers were able to “reprogram” these dormant cells to recognize and destroy cancer. Wed, 28 Jan 2026 09:57:00 EST https://www.sciencedaily.com/releases/2026/01/260127112137.htm https://www.sciencedaily.com/releases/2026/01/260127010149.htm Researchers have discovered a biological switch that explains why movement keeps bones strong. The protein senses physical activity and pushes bone marrow stem cells to build bone instead of storing fat, slowing age-related bone loss. By targeting this “exercise sensor,” scientists believe they could create drugs that mimic exercise at the molecular level. The approach could protect fragile bones in people who are unable to stay active. Tue, 27 Jan 2026 09:48:33 EST https://www.sciencedaily.com/releases/2026/01/260127010149.htm https://www.sciencedaily.com/releases/2026/01/260125083344.htm Cancer doesn’t evolve by pure chaos. Scientists have developed a powerful new method that reveals the hidden rules guiding how cancer cells gain and lose whole chromosomes—massive genetic shifts that help tumors grow, adapt, and survive treatment. By tracking thousands of individual cells over time, the approach shows which chromosome combinations give cancer an edge and why some tumors become especially resilient. Mon, 26 Jan 2026 04:41:20 EST https://www.sciencedaily.com/releases/2026/01/260125083344.htm https://www.sciencedaily.com/releases/2026/01/260124003811.htm Pancreatic cancer may evade the immune system using a clever molecular trick. Researchers found that the cancer-driving protein MYC also suppresses immune alarm signals, allowing tumors to grow unnoticed. When this immune-shielding ability was disabled in animal models, tumors rapidly collapsed. The findings point to a new way to expose cancer to the body’s own defenses without harming healthy cells. Sat, 24 Jan 2026 00:38:11 EST https://www.sciencedaily.com/releases/2026/01/260124003811.htm https://www.sciencedaily.com/releases/2026/01/260122074030.htm Researchers have identified a promising new weapon against triple-negative breast cancer, one of the most aggressive forms of the disease. An experimental antibody targets a protein that fuels tumor growth and shuts down immune defenses, effectively turning the immune system back on. In early tests, the treatment slowed tumor growth, reduced lung metastases, and destroyed chemotherapy-resistant cancer cells. Thu, 22 Jan 2026 23:43:30 EST https://www.sciencedaily.com/releases/2026/01/260122074030.htm https://www.sciencedaily.com/releases/2026/01/260120000323.htm Ibuprofen may be doing more than easing aches and pains—it could also help reduce the risk of some cancers. Studies have linked regular use to lower rates of endometrial and bowel cancer, likely because the drug dampens inflammation that fuels tumor growth. Researchers have even found it can interfere with genes cancer cells rely on to survive. Still, experts warn that long-term use carries risks and shouldn’t replace proven prevention strategies. Tue, 20 Jan 2026 03:47:11 EST https://www.sciencedaily.com/releases/2026/01/260120000323.htm https://www.sciencedaily.com/releases/2026/01/260116035351.htm Scientists have discovered that breast cancer can quietly throw the brain’s internal clock off balance—almost immediately after cancer begins. In mice, tumors flattened the natural daily rhythm of stress hormones, disrupting the brain-body feedback loop that regulates stress, sleep, and immunity. Remarkably, when researchers restored the correct day-night rhythm in specific brain neurons, stress hormone cycles snapped back into place, immune cells flooded the tumors, and the cancers shrank—without using any anti-cancer drugs. Sun, 18 Jan 2026 23:35:08 EST https://www.sciencedaily.com/releases/2026/01/260116035351.htm https://www.sciencedaily.com/releases/2026/01/260115022808.htm A vitamin A byproduct has been found to quietly disarm the immune system, allowing tumors to evade attack and weakening cancer vaccines. Scientists have now developed a drug that shuts down this pathway, dramatically boosting immune responses and slowing cancer growth in preclinical studies. Fri, 16 Jan 2026 06:06:55 EST https://www.sciencedaily.com/releases/2026/01/260115022808.htm https://www.sciencedaily.com/releases/2026/01/260114084129.htm Pancreatic cancer uses a sugar-coated disguise to evade the immune system, helping explain why it’s so hard to treat. Northwestern scientists discovered this hidden mechanism and created an antibody that strips away the tumor’s protective signal. In animal tests, immune cells sprang back into action and tumors grew much more slowly. The team is now refining the therapy for future human trials. Thu, 15 Jan 2026 02:10:05 EST https://www.sciencedaily.com/releases/2026/01/260114084129.htm https://www.sciencedaily.com/releases/2026/01/260112214313.htm Childbirth depends not just on hormones, but on the uterus’s ability to sense physical force. Scientists found that pressure and stretch sensors in uterine muscles and surrounding nerves work together to trigger coordinated contractions. When these sensors are disrupted, contractions weaken and delivery slows. The discovery helps explain stalled labor—and could one day lead to better ways to manage childbirth. Tue, 13 Jan 2026 08:34:15 EST https://www.sciencedaily.com/releases/2026/01/260112214313.htm https://www.sciencedaily.com/releases/2026/01/260107225532.htm Long COVID affects an estimated 65 million people worldwide and can damage the brain, heart, blood vessels, and immune system long after infection. Researchers now link symptoms to lingering virus, inflammation, micro-clots, and disrupted energy metabolism. While structured rehab and pacing can improve quality of life, a growing list of experimental treatments—from antivirals and metformin to microbiome therapies and biologics—shows early promise. Clear answers, however, are still limited by small studies and the lack of large, definitive trials. Thu, 08 Jan 2026 19:57:41 EST https://www.sciencedaily.com/releases/2026/01/260107225532.htm https://www.sciencedaily.com/releases/2026/01/260106224644.htm Global cancer cases have surged dramatically, doubling since 1990 and reaching 18.5 million new diagnoses in 2023. Deaths have also climbed to over 10 million a year, with the steepest increases hitting low- and middle-income countries. Without urgent action, researchers project more than 30 million new cases annually by 2050. Alarmingly, around four in ten cancer deaths are tied to preventable risks such as smoking, poor diet, and high blood sugar. Wed, 07 Jan 2026 02:57:53 EST https://www.sciencedaily.com/releases/2026/01/260106224644.htm https://www.sciencedaily.com/releases/2025/12/251228020010.htm A randomized trial from Vanderbilt-Ingram Cancer Center reveals that magnesium may be the missing key to keeping vitamin D levels in balance. The study found that magnesium raised vitamin D in people who were deficient while dialing it down in those with overly high levels—suggesting a powerful regulating effect. This could help explain why vitamin D supplements don’t work the same way for everyone and why past studies linking vitamin D to cancer and heart disease have produced mixed results. Sun, 28 Dec 2025 02:00:10 EST https://www.sciencedaily.com/releases/2025/12/251228020010.htm https://www.sciencedaily.com/releases/2025/12/251227082716.htm Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and how that risk might be reduced. They found that the vaccines can spark a two-step immune reaction that floods the body with inflammatory signals, drawing aggressive immune cells into the heart and causing temporary injury. Sat, 27 Dec 2025 10:52:27 EST https://www.sciencedaily.com/releases/2025/12/251227082716.htm https://www.sciencedaily.com/releases/2025/12/251227004155.htm Researchers have discovered how cells activate a last-resort DNA repair system when severe damage strikes. When genetic tangles overwhelm normal repair pathways, cells flip on a fast but error-prone emergency fix that helps them survive. Some cancer cells rely heavily on this backup system, even though it makes their DNA more unstable. Blocking this process could expose a powerful new way to target tumors. Sat, 27 Dec 2025 06:20:32 EST https://www.sciencedaily.com/releases/2025/12/251227004155.htm https://www.sciencedaily.com/releases/2025/12/251222044058.htm Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells more effectively. Their strategy targets a hidden “off switch” that tumors use to stay invisible to immune defenses—special sugar molecules on the cancer cell surface that suppress immune activity. Early tests show it can supercharge immune responses and outperform current antibody therapies. Tue, 23 Dec 2025 08:54:27 EST https://www.sciencedaily.com/releases/2025/12/251222044058.htm https://www.sciencedaily.com/releases/2025/12/251221091243.htm Menopause symptoms are common among female endurance athletes and often interfere with training and performance. A survey of women aged 40–60 who train regularly found high rates of sleep problems, exhaustion, anxiety, weight gain, and joint pain. Many athletes said these symptoms made it harder to train effectively or perform at their best. The results highlight a need for greater attention to menopause in active women. Fri, 02 Jan 2026 15:34:01 EST https://www.sciencedaily.com/releases/2025/12/251221091243.htm https://www.sciencedaily.com/releases/2025/12/251215025315.htm Scientists have discovered that key compounds from cannabis—CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce colony formation, and may even block the cancer’s ability to spread. Even more promising, the treatment caused minimal harm to healthy cells and appears to work by restoring a disrupted signaling pathway that fuels tumor growth. Mon, 15 Dec 2025 03:22:06 EST https://www.sciencedaily.com/releases/2025/12/251215025315.htm https://www.sciencedaily.com/releases/2025/12/251213032615.htm Researchers used a deep learning AI model to uncover the first imaging-based biomarker of chronic stress by measuring adrenal gland volume on routine CT scans. This new metric, the Adrenal Volume Index, correlates strongly with cortisol levels, allostatic load, perceived stress, and even long-term cardiovascular outcomes, including heart failure risk. Sun, 14 Dec 2025 09:27:30 EST https://www.sciencedaily.com/releases/2025/12/251213032615.htm https://www.sciencedaily.com/releases/2025/12/251213032613.htm A decade-long study of older women found that tea drinkers had slightly stronger bones, while moderate coffee drinking caused no harm. Heavy coffee intake—over five cups a day—was linked to lower bone density, especially in women who consumed more alcohol. Tea’s benefits may stem from catechins that support bone formation. The researchers say small daily habits could make a meaningful difference over time. Sat, 13 Dec 2025 11:49:28 EST https://www.sciencedaily.com/releases/2025/12/251213032613.htm https://www.sciencedaily.com/releases/2025/12/251209043050.htm New research is challenging one of medicine’s oldest assumptions: that cancer must be attacked to be cured. By treating glioblastoma patients with a simple combination of resveratrol and copper, the researchers found dramatic reductions in tumor aggressiveness, cancer biomarkers, immune checkpoints, and stem-cell–related markers—all without side effects. Their approach focuses on “healing” tumors by eliminating harmful cell-free chromatin particles released from dying cancer cells, which normally inflame and worsen the disease. The findings hint at a future where inexpensive nutraceuticals could transform cancer therapy. Wed, 10 Dec 2025 03:56:21 EST https://www.sciencedaily.com/releases/2025/12/251209043050.htm